<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03125707</url>
  </required_header>
  <id_info>
    <org_study_id>MPN Registry - Ulm</org_study_id>
    <nct_id>NCT03125707</nct_id>
  </id_info>
  <brief_title>German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)</brief_title>
  <official_title>German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid
      neoplasm (according to WHO 2008 classification) in participating centers

      To store samples from all patients (e.g. bone marrow aspirate, peripheral blood, plasma, and
      buccal swap, skin biopsy samples in exceptional cases)

      To perform morphologic and genetic analyses

      To assess clinical characteristics and outcome data using a defined catalogue containing
      clinically relevant variables

      To assess biological disease features and correlate with clinical outcome data (prognostic
      and predictive markers)

      To assess quality of life
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid
      neoplasm (according to WHO 2008 classification) in participating centers

      To store samples from all patients (e.g. bone marrow aspirate, peripheral blood, plasma, and
      buccal swap, skin biopsy samples in exceptional cases)

      To perform morphologic and genetic analyses

      To assess clinical characteristics and outcome data using a defined catalogue containing
      clinically relevant variables

      To assess biological disease features and correlate with clinical outcome data (prognostic
      and predictive markers)

      To assess quality of life
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">January 2038</completion_date>
  <primary_completion_date type="Anticipated">January 2037</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Treatment decision</measure>
    <time_frame>20 years</time_frame>
    <description>Treatment decision (watch and wait, standard, investigational)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Response</measure>
    <time_frame>20 years</time_frame>
    <description>Response of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>20 years</time_frame>
    <description>Survival over the whole study duration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression-free-survival</measure>
    <time_frame>20 years</time_frame>
    <description>Survival without any progression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of response</measure>
    <time_frame>20 years</time_frame>
    <description>Duration of response over the whole study duration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>20 years</time_frame>
    <description>Quality of life assessed by the Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF Protocol 5/25/11), supplemented by information on self-assessed concomitant diseases and demographics.</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>BCR-ABL1-Negative Myeloid Neoplasms</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registry study</intervention_name>
    <description>not available</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with the diagnosis of a BCR-ABL 1-negative myeloid neoplasm in participating
        centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Both female and male patients meeting the mentioned inclusion criteria will be included in
        this registry, because the risk to get a myeloid neoplasm does not depend on a patient's
        gender. Patients must meet all of the following inclusion criteria to be eligible for
        enrollment into the registry:

          -  Patients with suspected diagnosis of one of the following BCR-ABL1-negative myeloid
             neoplasm:

          -  Myeloproliferative neoplasm according to WHO 2008

          -  Myeloid neoplasm associated with eosinophilia and abnormalities of PDGFRA, PDGFRB, or
             FGFR1 according to WHO 2008

          -  Secondary myelofibrosis following ET or PV according to IWG-MRT criteria

          -  Age ≥ 18 years. There is no upper age limit.

          -  Signed written informed consent.

        Exclusion Criteria:

          -  Severe neurological or psychiatric disorder interfering with ability to give an
             informed consent

          -  No consent for registration, storage and processing of the individual disease
             characteristics and course BCR-ABL1-positive chronic myeloid leukemia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frank Stegelmann, Dr.</last_name>
    <phone>+4973150045521</phone>
    <email>frank.stegelmann@uniklinik-ulm.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hämatologische Onkologie Praxis Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Bangerter, Prof. Dr.</last_name>
      <phone>+498213446520</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Hirschbühl, Dr.</last_name>
      <phone>+498214003715</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum, Bad Saarow</name>
      <address>
        <city>Bad Saarow</city>
        <zip>15526</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Bitz, Dr.</last_name>
      <phone>+493363173728</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologie, BAG, Dreseden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Illmer, Dr.</last_name>
      <phone>+493514400022</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cornelius Waller, Prof. Dr.</last_name>
      <phone>+497612700</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alb Fils Kliniken Göppingen</name>
      <address>
        <city>Göppingen</city>
        <zip>73035</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Bommer, PD Dr.</last_name>
      <phone>+497161642962</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Praxis, Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Karcher, Dr.</last_name>
      <phone>+496221453281</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis Heilbronn</name>
      <address>
        <city>Heilbronn</city>
        <zip>74072</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jolenta Dengler, Dr.</last_name>
      <phone>07131 79774979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marienhospital Bochum-Herne</name>
      <address>
        <city>Herne</city>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beate Schultheis, Dr.</last_name>
      <phone>+4923234991575</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Hochhaus, Prof. Dr.</last_name>
      <phone>+4936419300</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dietger Niederwieser, Prof. Dr.</last_name>
      <phone>+493419713061</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Wolleschak, Dr.</last_name>
      <phone>+4916713134</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Kindler, Dr.</last_name>
      <phone>+496131175160</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Reiter, Prof. Dr.</last_name>
      <phone>+496213830</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mühlenkreiskliniken Minden</name>
      <address>
        <city>Minden</city>
        <zip>32429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Griesshammer, Prof. Dr.</last_name>
      <phone>+495717901184</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stauferklinikum Schwäbisch Gmünd</name>
      <address>
        <city>Mutlangen</city>
        <zip>73557</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Hebart, Prof. Dr.</last_name>
      <phone>+4971717011397</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diakonie-Klinikum Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <zip>70176</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Greiner, Prof. Dr.</last_name>
      <phone>+497119913517</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Stegelmann, Dr.</last_name>
      <phone>+4973150045919</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rems-Murr-Kliniken Winnenden</name>
      <address>
        <city>Winnenden</city>
        <zip>71334</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Parmentier, Dr.</last_name>
      <phone>+49719559136022</phone>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Frank Stegelmann</investigator_full_name>
    <investigator_title>Principal Investigator Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

